ESMO 2026 has ended. This guide stays up as the record of who was there. Next: ESMO 2027, Sep 17–21, 2027 in Barcelona
HC
Henan Cancer Hospital at ESMO 2026
Oct 23–27, 2026 Madrid, Spain ~37k attendees Website
Henan Cancer Hospital takes part in 9 sessions at ESMO 2026 in Madrid. Its work spans lung, breast, gastrointestinal and gynaecological cancers, alongside rare cancers and biomarkers. Specific topics include targeted treatments for advanced breast cancer, therapies for lung cancer and immune-cell treatments for solid tumours.
| Organization | ESMO 2026 Attendance |
|---|---|
HC Henan Cancer Hospital Zhengzhou, China | |
Cancer hospital in Zhengzhou, China. | Poster Fri Oct 23 13:00–15:00 Poster Fri Oct 23 15:15–16:00 Poster Fri Oct 23 15:15–16:00 Poster Fri Oct 23 15:15–16:00 Longitudinal CSF ctDNA profiling for molecular monitoring of leptomeningeal metastasis in advanced NSCLC Sarcoma, CNS, head & neck and rare cancersBiomarkers & precision oncology Poster Sat Oct 24 12:00–12:45 Poster Sat Oct 24 12:00–12:45 Poster Sat Oct 24 12:00–12:45 Poster Sat Oct 24 12:00–12:45 Poster Sun Oct 25 12:00–12:45 Poster Mon Oct 26 12:00–12:45 High-dose furmonertinib combined with bevacizumab and pemetrexed in patients with EGFR-mutated NSCLC and LM: An ambispective real-world study Lung & thoracic cancersSarcoma, CNS, head & neck and rare cancers Poster Mon Oct 26 12:00–12:45 Poster Mon Oct 26 12:00–12:45 Updated overall survival results from the phase 1 dose escalation and expansion study of alveltamig (ZG006), a trispecific T cell engager targeting DLL3/DLL3/CD3, as monotherapy in patients with refractory small cell lung cancer or neuroendocrine carcinoma with longer follow up Lung & thoracic cancersSarcoma, CNS, head & neck and rare cancers |
Find decision makers at Henan Cancer Hospital
Tell us what you sell and we’ll find the people at Henan Cancer Hospital most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction